SecBot SecBot
8-K ·Filed May 7, 2026

GGZ

Gabelli Global Small & Mid Cap Value Trust
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001829126-26-004783
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor for further updates on Mr. Gabelli's health and any potential changes to the Fund's management or investment strategy if his absence becomes prolonged. The activation of a succession plan suggests continuity, but the uncertainty around his return adds mild risk.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GGZ ▲ +4.22% at T+60d
NEUTRAL call +4.22% · α vs SPY -0.62% · entry $16.01 → $16.69
Entry = T+0 close
May 7, 2026
via day close
T+1d
-0.37%
call -0.37% · α -0.61%
$15.95
settled 6mo ago
T+5d
-1.87%
call -1.87% · α -3.34%
$15.71
settled 6mo ago
T+20d
-3.06%
call -3.06% · α -3.08%
$15.52
settled 5mo ago
T+60d
+4.22%
call +4.22% · α -0.62%
$16.69
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Gabelli Global Small & Mid Cap Value Trust filed an 8-K disclosing that Mario J. Gabelli was hospitalized on March 19, 2026, after a medical incident. His condition is improving but his return timeline is unknown. The parent company GAMCO implemented a pre-existing succession plan, with Christopher J. Marangi named President and the day-to-day operations continuing under co-CEOs. This is a routine update with no immediate financial impact.

Key Facts

  • Mario J. Gabelli, Trustee, Chairman, and CIO of the Fund, was hospitalized on March 19, 2026, after a medical incident.
  • His condition is improving but the timeline for his return is not yet known.
  • GAMCO implemented its pre-existing succession plan on March 22, 2026; Christopher J. Marangi was named President of GAMCO.
  • Day-to-day operations of GAMCO continue under co-CEOs Douglas R. Jamieson and Christopher J. Marangi.
  • Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team for the Fund during Mr. Gabelli's absence.

Financial Impact

No financial impact reported; no material financial disclosure.

Risk Factors

  • Prolonged absence of Mario Gabelli could lead to management turnover or strategic shifts.
  • Potential negative market perception if recovery timeline extends significantly.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001829126-26-004783
Document: 0001829126-26-004783-index-headers.html0001829126-26-004783
Document: 0001829126-26-004783-index.html0001829126-26-004783
Document: 0001829126-26-004783.txt0001829126-26-004783
4 reports for GGZ
Performance horizon
Filters
Rows
Reports for GGZ — sortable, filterable
TypeNow
Aug 17, 2026
10w ago
3
NEUTRAL ★ 2/10
$16.94 $16.04▼ −5.32%▼ −3.35%$14.81 (−12.57%)
Aug 12, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$16.70 $15.96▼ −4.46%▼ −2.56%$14.81 (−11.32%)
May 13, 2026
23w ago
Press Release
NEUTRAL ★ 2/10
$15.60 $15.65▲ +0.34%▲ +0.95%$14.81 (−5.06%)
May 7, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$16.01 $15.52▼ −3.06%▼ −3.08%$14.81 (−7.50%)
Showing 4 of 4

US Market Status

Market Closed — Opens Tue (15h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026